본문으로 건너뛰기
← 뒤로

MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.

1/5 보강
Respiratory research 📖 저널 OA 85.2% 2025: 9/9 OA 2026: 14/18 OA 2025~2026 2026 OA Ferroptosis and cancer prognosis
Retraction 확인
출처
PubMed DOI OpenAlex 마지막 보강 2026-04-29
OpenAlex 토픽 · Ferroptosis and cancer prognosis Cancer Cells and Metastasis Cancer, Lipids, and Metabolism

Yi Y, Hu Y, Ren S, Wu Y, Chen X, Lu Y

📖 무료 전문 🔓 OA PDF oa

이 논문을 인용하기

↓ .bib ↓ .ris
APA Yanjun Yi, 虎毅 杜, et al. (2026). MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.. Respiratory research. https://doi.org/10.1186/s12931-026-03673-8
MLA Yanjun Yi, et al.. "MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.." Respiratory research, 2026.
PMID 41998662 ↗

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🔓 OA PDF 열기